Nicolet Bankshares’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$857K Buy
6,129
+4,479
+271% +$627K 0.03% 313
2025
Q4
$203K Buy
+1,650
New +$201K 0.03% 223
2017
Q3
Sell
-2,651
Closed -$188K 172
2017
Q2
$188K Sell
2,651
-4,738
-64% -$315K 0.09% 168
2017
Q1
$502K Buy
7,389
+2,109
+40% +$148K 0.26% 75
2016
Q4
$378K Buy
5,280
+790
+18% +$58.7K 0.21% 91
2016
Q3
$355K Sell
4,490
-854
-16% -$69.4K 0.21% 102
2016
Q2
$446K Buy
5,344
+584
+12% +$51.8K 0.29% 75
2016
Q1
$437K Buy
4,760
+117
+3% +$10.6K 0.31% 68
2015
Q4
$385K Buy
+4,643
New +$483K 0.38% 67

Other funds holding GILD

Nicolet Bankshares's GILD Position: Q1 2026 in Review

Nicolet Bankshares increased its Gilead Sciences (GILD) stake by 271% in Q1 2026, buying an estimated $627K and bringing the position to 6,129 shares worth $857K. The position accounts for 0.03% of the portfolio, ranked #313.

Nicolet Bankshares first reported a position in GILD in Q4 2015 and has held it in 9 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Nicolet Bankshares held 6,129 shares of Gilead Sciences worth $857K as of Q1 2026.
  • Nicolet Bankshares bought 4,479 Gilead Sciences shares in Q1 2026, an estimated $627K.
  • Gilead Sciences made up 0.03% of Nicolet Bankshares's portfolio in Q1 2026, its #313 holding.
  • Nicolet Bankshares first reported a position in Gilead Sciences in Q4 2015 and has held it in 9 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Nicolet Bankshares's 13F filing for Q1 2026, filed 14 May 2026.